Then, sample data from 487 PTC patients (198 with BRAFwt and 289 with BRAFmut) and 469 melanoma patients (229 with BRAFwt and 240 with BRAFmut) extracted from the TCGA were divided into two groups according to the BRAF mutation status. The gene discussed is BRAF; the disease is melanoma.